Corcept Therapeutics
CORT
#1654
Rank
NZ$22.78 B
Marketcap
NZ$210.82
Share price
-0.89%
Change (1 day)
37.15%
Change (1 year)

EPS for Corcept Therapeutics (CORT)

EPS in 2026 (TTM): NZ$0.91

According to Corcept Therapeutics 's latest financial reports the company's current EPS (TTM) is NZ$0.92. In 2025 the company made an earnings per share (EPS) of NZ$1.67 a decrease over its 2024 EPS that were of NZ$2.40.

EPS history for Corcept Therapeutics from 2017 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$0.91-45.65%
2025NZ$1.67-30.37%
2024NZ$2.40
2022NZ$1.69-2.06%
2021NZ$1.735.43%
2020NZ$1.6410.84%
2019NZ$1.4827.69%
2018NZ$1.16-42.48%
2017NZ$2.01

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.53 1,579.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$11.84 1,180.77%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$1.35 46.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$53.15 5,646.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$2.25 143.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$8.07 773.08%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
NZ-$0.23-125.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
NZ-$0.03557-103.85%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$0.68-26.92%๐Ÿ‡บ๐Ÿ‡ธ USA